Brainsight Technology, incorporated in 2019, is a healthtech company that provides evidence-based treatment hooks for neurosurgeons, psychiatrists and neurologists, along with private and digital aids for patients and related business activities. The company has focused product offerings for clinical specialists in neurology and psychiatry. It remained at or near pre-revenue until FY23, when operating revenue grew 25.3% to Rs 27.5 lakhs. The firm reported losses of Rs 3.28 crore in the last fiscal year. Brainsight's commercial traction appears limited based on disclosed FY23 numbers, and the company continues to rely on external strategic investments to support its operations and growth. BrainSightAI is a Bengaluru-based deep-tech company offering an MRI-based SaaS platform to improve precision in neurological and psychiatric investigation. The platform aims to enable more precise diagnosis and data-informed treatment planning for neuro-oncological and neuropsychiatric disorders. The company says its technology helps shorten patients' path to recovery by moving from informed estimation to data-assured diagnosis and data-predicted prognosis. BrainSightAI has received ecosystem support, including admission to the GE Edison Accelerator and Dassault Systèmes' 3DEXPERIENCE program. It also won the BIRAC BIG 15 grant from the Government of India in January 2020 to conduct clinical studies on brain-function alteration in dementia. The company plans to use the new capital to further its mission of improving diagnostic and treatment precision.

Total raised

$1M

Funding rounds

2

Latest round

Convertible Note

Latest activity

Jul 2023